{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:51:03Z","timestamp":1781833863806,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.isci.2026.115588","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:58:02Z","timestamp":1775231882000},"page":"115588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The YAP1-NPM1 nuclear complex regulates MYC and reveals a targetable oncogenic node"],"prefix":"10.1016","volume":"29","author":[{"given":"Abdulrahman M.","family":"Dwead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah M.","family":"Al-Mathkour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Khanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Akbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-865X","authenticated-orcid":false,"given":"Bekir","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115588_bib1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"Totaro","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2026.115588_bib2","first-page":"9","article-title":"YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.115588_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.devcel.2021.12.006","article-title":"YAP1 and PRDM14 converge to promote cell survival and tumorigenesis","volume":"57","author":"Kim","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2026.115588_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","article-title":"The Hippo Signaling Pathway in Development and Disease","volume":"50","author":"Zheng","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2026.115588_bib5","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease","volume":"18","author":"Panciera","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115588_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115588_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nm.3562","article-title":"Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers","volume":"20","author":"Cottini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115588_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","article-title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene","volume":"16","author":"Zhou","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.115588_bib9","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","article-title":"YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis","volume":"54","author":"Wu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.115588_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41467-019-13771-5","article-title":"YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation","volume":"11","author":"Tsuji","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115588_bib11","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41467-022-30831-5","article-title":"YAP inhibits ER\u03b1 and ER(+) breast cancer growth by disrupting a TEAD-ER\u03b1 signaling axis","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115588_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","article-title":"Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis","volume":"20","author":"Touil","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ccell.2017.09.007","article-title":"A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer","volume":"32","author":"Mello","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.115588_bib14","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1038\/ncomms9126","article-title":"YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer","volume":"6","author":"Kuser-Abali","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115588_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccell.2015.05.005","article-title":"ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors","volume":"27","author":"Nguyen","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.115588_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005465","article-title":"YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers","volume":"11","author":"Stein","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2026.115588_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56022-9","article-title":"AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma","volume":"9","author":"Jia","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115588_bib18","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112184","article-title":"YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth","volume":"42","author":"Li","year":"2023","journal-title":"Embo j"},{"key":"10.1016\/j.isci.2026.115588_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-022-28691-0","article-title":"Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER(+) breast cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115588_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molcel.2019.06.010","article-title":"A Non-canonical Role of YAP\/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer","volume":"75","author":"Zhu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.115588_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41420-023-01319-y","article-title":"Verteporfin reverses progestin resistance through YAP\/TAZ-PI3K-Akt pathway in endometrial carcinoma","volume":"9","author":"Wei","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2026.115588_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110009","article-title":"CDC42 controlled apical-basal polarity regulates intestinal stem cell to transit amplifying cell fate transition via YAP-EGF-mTOR signaling","volume":"38","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115588_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","article-title":"YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance","volume":"475","author":"Szulzewsky","year":"2021","journal-title":"Dev. Biol."},{"key":"10.1016\/j.isci.2026.115588_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-binding proteins","volume":"19","author":"Hentze","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115588_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0092-8674(89)90241-9","article-title":"Major nucleolar proteins shuttle between nucleus and cytoplasm","volume":"56","author":"Borer","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115588_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000920","article-title":"Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation","volume":"18","author":"Akef","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.isci.2026.115588_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118879","article-title":"The interaction between nucleophosmin\/NPM1 and the large ribosomal subunit precursors contribute to maintaining the nucleolar structure","volume":"1868","author":"Okuwaki","year":"2021","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"10.1016\/j.isci.2026.115588_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008463","article-title":"NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes","volume":"15","author":"Darracq","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2026.115588_bib29","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/0008-5472.CAN-22-3631","article-title":"Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment","volume":"83","author":"Sekhar","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hon.904","article-title":"Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity","volume":"27","author":"Rau","year":"2009","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.115588_bib31","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/MCB.01969-08","article-title":"Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation","volume":"29","author":"Shandilya","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115588_bib32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41589-022-01062-y","article-title":"Systematic discovery of biomolecular condensate-specific protein phosphorylation","volume":"18","author":"Sridharan","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2026.115588_bib33","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201903183RRR","article-title":"NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia","volume":"35","author":"Tang","year":"2021","journal-title":"Faseb j"},{"key":"10.1016\/j.isci.2026.115588_bib34","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/MCB.01064-14","article-title":"TRIM28 Is an E3 Ligase for ARF-Mediated NPM1\/B23 SUMOylation That Represses Centrosome Amplification","volume":"35","author":"Neo","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115588_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0092-8674(00)00093-3","article-title":"Nucleophosmin\/B23 is a target of CDK2\/cyclin E in centrosome duplication","volume":"103","author":"Okuda","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115588_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719899818","article-title":"Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia","volume":"11","author":"Chen","year":"2020","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.isci.2026.115588_bib37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/1440-1681.13628","article-title":"High expression of NPM1 via the Wnt\/\u03b2-catenin signalling pathway might predict poor prognosis for patients with prostate adenocarcinoma","volume":"49","author":"Ruan","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.isci.2026.115588_bib38","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-020-15364-z","article-title":"NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer","volume":"11","author":"Qin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115588_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107964","article-title":"Discordant interactions between YAP1 and polycomb group protein SCML2 determine cell fate","volume":"26","author":"Boston","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.115588_bib40","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib41","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1074\/jbc.RA120.013794","article-title":"Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity","volume":"295","author":"Cinar","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115588_bib42","first-page":"27","article-title":"Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer","volume":"8","author":"Golshayan","year":"2013","journal-title":"Core Evid."},{"key":"10.1016\/j.isci.2026.115588_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144885","article-title":"Nucleophosmin in Its Interaction with Ligands","volume":"21","author":"Cela","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115588_bib44","doi-asserted-by":"crossref","first-page":"26539","DOI":"10.1074\/jbc.M112.371013","article-title":"Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter","volume":"287","author":"Gallo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115588_bib45","doi-asserted-by":"crossref","first-page":"18794","DOI":"10.1073\/pnas.0806879105","article-title":"Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115588_bib46","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/onc.2012.227","article-title":"Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription","volume":"32","author":"Li","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.115588_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.devcel.2019.07.022","article-title":"A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas","volume":"51","author":"Murakami","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2026.115588_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1101\/gad.316570.118","article-title":"Polycystic kidney disease: a Hippo connection","volume":"32","author":"Ma","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2026.115588_bib49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41587-025-02648-2","article-title":"Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein","volume":"44","author":"George","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.115588_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1363361","article-title":"Plasticity in cell migration modes across development, physiology, and disease","volume":"12","author":"Pourjafar","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2026.115588_bib51","doi-asserted-by":"crossref","DOI":"10.1515\/med-2023-0708","article-title":"Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis","volume":"18","author":"Yang","year":"2023","journal-title":"Open Med."},{"key":"10.1016\/j.isci.2026.115588_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3892\/mmr.2016.6033","article-title":"High expression of B23 is associated with tumorigenesis and poor prognosis in bladder urothelial carcinoma","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.isci.2026.115588_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096293","article-title":"NPM1 silencing reduces tumour growth and MAPK signalling in prostate cancer cells","volume":"9","author":"Loubeau","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115588_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115588_bib55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115588_bib56","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1158\/0008-5472.CAN-10-4532","article-title":"MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling","volume":"71","author":"Cinar","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184590","article-title":"Mapping the STK4\/Hippo signaling network in prostate cancer cell","volume":"12","author":"Ready","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115588_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jb\/mvm222","article-title":"The structure and functions of NPM1\/Nucleophsmin\/B23, a multifunctional nucleolar acidic protein","volume":"143","author":"Okuwaki","year":"2008","journal-title":"J. Biochem."},{"key":"10.1016\/j.isci.2026.115588_bib59","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1016\/j.molcel.2024.08.021","article-title":"An RNA-centric view of transcription and genome organization","volume":"84","author":"Henninger","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.115588_bib60","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41598-020-80224-1","article-title":"NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization","volume":"11","author":"\u0160a\u0161inkov\u00e1","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115588_bib61","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/onc.2008.54","article-title":"NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells","volume":"27","author":"Qi","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.115588_bib62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/genes11060649","article-title":"Nucleophosmin 1 Mutations in Acute Myeloid Leukemia","volume":"11","author":"Zarka","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.isci.2026.115588_bib63","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","article-title":"Current status and future perspectives in targeted therapy of NPM1-mutated AML","volume":"36","author":"Ranieri","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.115588_bib64","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41588-025-02408-7","article-title":"Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation","volume":"58","author":"Kanellos","year":"2026","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.115588_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1158\/2159-8290.CD-22-0424","article-title":"Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia","volume":"13","author":"Wang","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.115588_bib66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7150\/ijbs.13382","article-title":"Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras\/ERK MAPK Signaling","volume":"12","author":"Xian","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2026.115588_bib67","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41467-025-56634-y","article-title":"Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition","volume":"16","author":"Paul","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115588_bib68","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.115588_bib69","first-page":"452","article-title":"The Role of NPM1 in the Invasion and Migration of Drug Resistant Bladder Cancer","volume":"18","author":"Luo","year":"2021","journal-title":"Urol. J."},{"key":"10.1016\/j.isci.2026.115588_bib70","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1158\/0008-5472.CAN-19-3782","article-title":"Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer","volume":"80","author":"Li","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib71","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1038\/s41388-021-02040-9","article-title":"Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1","volume":"40","author":"Yan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.115588_bib72","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1158\/0008-5472.CAN-20-0907","article-title":"YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice","volume":"80","author":"Park","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib73","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-23-2994","article-title":"TEAD Inhibition Overcomes YAP1\/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors","volume":"83","author":"Edwards","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115588_bib74","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1878-0261.12999","article-title":"Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1","volume":"15","author":"Kandasamy","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.isci.2026.115588_bib75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: a signalling hub of the tumour microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115588_bib76","article-title":"NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115588_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216498","article-title":"Pumilio1 regulates NPM3\/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer","volume":"581","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.115588_bib78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-023-06053-y","article-title":"YAP1 expression is associated with survival and immunosuppression in small cell lung cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.115588_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2326-6066.CIR-17-0320","article-title":"YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma","volume":"6","author":"Kim","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.115588_bib85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj20031661","article-title":"Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells","volume":"379","author":"Cinar","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.115588_bib80","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1038\/s41598-022-07790-4","article-title":"The Hippo effector YAP1\/TEAD1 regulates EPHA3 expression to control cell contact and motility","volume":"12","author":"Al-Mathkour","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115588_bib81","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M112.358713","article-title":"Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase\/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1","volume":"287","author":"Collak","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115588_bib82","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.115588_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115588_bib84","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226009636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226009636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:04:09Z","timestamp":1781831049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226009636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2589004226009636"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115588","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The YAP1-NPM1 nuclear complex regulates MYC and reveals a targetable oncogenic node","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115588"}}